Cargando…

Efficacy of Vandetanib in Treating Locally Advanced or Metastatic Medullary Thyroid Carcinoma According to RECIST Criteria: A Systematic Review and Meta-Analysis

BACKGROUND: Vandetanib is the most largely used tyrosine kinase inhibitor (TKI) in patients with locally advanced and/or metastatic medullary thyroid cancer (MTC). Here, we conducted a systematic review on its efficacy and attempted to perform a meta-analysis adopting standardized RECIST criteria as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trimboli, Pierpaolo, Castellana, Marco, Virili, Camilla, Giorgino, Francesco, Giovanella, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943569/ https://www.ncbi.nlm.nih.gov/pubmed/29774010 http://dx.doi.org/10.3389/fendo.2018.00224

Ejemplares similares

Thyroxine Treatment With Softgel Capsule Formulation: Usefulness in Hypothyroid Patients Without Malabsorption
por: Trimboli, Pierpaolo, et al.
Publicado: (2018)

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
por: Degrauwe, Nils, et al.
Publicado: (2012)

Procalcitonin as Marker of Recurrent Medullary Thyroid Carcinoma: A Systematic Review and Meta-Analysis
por: Trimboli, Pierpaolo, et al.
Publicado: (2018)

Levothyroxine Therapy: Changes of TSH Levels by Switching Patients from Tablet to Liquid Formulation. A Systematic Review and Meta-Analysis
por: Virili, Camilla, et al.
Publicado: (2018)

Galectin-3 Performance in Histologic and Cytologic Assessment of Thyroid Nodules: A Systematic Review and Meta-Analysis
por: Trimboli, Pierpaolo, et al.
Publicado: (2017)

Role of vandetanib in the management of medullary thyroid cancer
por: Brassard, Maryse, et al.
Publicado: (2012)

Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid Cancer
por: Del Rivero, Jaydira, et al.
Publicado: (2018)

Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer
por: Deshpande, Hari, et al.
Publicado: (2011)

Phototoxic drug eruption induced by vandetanib used for the treatment of metastatic medullary thyroid cancer()
por: Bostan, Ecem, et al.
Publicado: (2022)

Procalcitonin measurement to screen medullary thyroid carcinoma: A prospective evaluation in a series of 2705 patients with thyroid nodules
por: Giovanella, Luca, et al.
Publicado: (2018)

Performance of (18)F-FDG PET/CT in Selecting Thyroid Nodules with Indeterminate Fine-Needle Aspiration Cytology for Surgery. A Systematic Review and a Meta-Analysis
por: Castellana, Marco, et al.
Publicado: (2019)

Clinical utility of vandetanib in the treatment of patients with advanced medullary thyroid cancer
por: Deshpande, Hari, et al.
Publicado: (2011)

Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
por: Fallahi, Poupak, et al.
Publicado: (2019)

Patterns of thyroid hormone levels in pediatric medullary thyroid carcinoma patients on vandetanib therapy
por: Lodish, Maya, et al.
Publicado: (2015)

The Significance of Having an Excellent Patient's Comfort with Thyroid Core Needle Biopsy
por: Trimboli, Pierpaolo, et al.
Publicado: (2018)

Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies
por: Grande, Enrique, et al.
Publicado: (2013)

What about TSH and Anti-Thyroid Antibodies in Patients with Autoimmune Thyroiditis and Celiac Disease Using a Gluten-Free Diet? A Systematic Review
por: Malandrini, Sabrina, et al.
Publicado: (2022)

The ultrasound risk stratification systems for thyroid nodule have been evaluated against papillary carcinoma. A meta-analysis
por: Trimboli, Pierpaolo, et al.
Publicado: (2020)

Reliability of core needle biopsy as a second-line procedure in thyroid nodules with an indeterminate fine-needle aspiration report: a systematic review and meta-analysis
por: Trimboli, Pierpaolo, et al.
Publicado: (2018)

Vandetanib for the Management of Advanced Medullary Thyroid Cancer: A Real-World Multicenter Experience
por: Kim, Mijin, et al.
Publicado: (2020)

Diagnostic tests for medullary thyroid carcinoma: an umbrella review
por: Trimboli, Pierpaolo, et al.
Publicado: (2023)

Vandetanib versus Cabozantinib in Medullary Thyroid Carcinoma: A Focus on Anti-Angiogenic Effects in Zebrafish Model
por: Carra, Silvia, et al.
Publicado: (2021)

Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration
por: Ferrari, Silvia Martina, et al.
Publicado: (2018)

Cancer Rate of the Indeterminate Lesions at Low or High Risk According to Italian System for Reporting of Thyroid FNA
por: Valabrega, Stefano, et al.
Publicado: (2018)

Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment
por: Werner, R.A., et al.
Publicado: (2015)

Effect of Vandetanib Treatment on Cystic Changes in the Liver following Metastasis from Medullary Thyroid Carcinoma
por: Matsui, Ai, et al.
Publicado: (2022)

Thyroid Inconveniences With Vaccination Against SARS-CoV-2: The Size of the Matter. A Systematic Review
por: Caironi, Verdiana, et al.
Publicado: (2022)

RECIST criteria: our experience in daily practice
por: De Luca, S, et al.
Publicado: (2015)

Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment: Erratum
Publicado: (2016)

COVID-19-Associated Subacute Thyroiditis: Evidence-Based Data From a Systematic Review
por: Trimboli, Pierpaolo, et al.
Publicado: (2021)

Systemic Lupus Erythematosus and Thyroid Autoimmunity
por: Ferrari, Silvia Martina, et al.
Publicado: (2017)

Hashimoto’s Thyroiditis and Autoimmune Gastritis
por: Cellini, Miriam, et al.
Publicado: (2017)

Pazopanib, Cabozantinib, and Vandetanib in the Treatment of Progressive Medullary Thyroid Cancer with a Special Focus on the Adverse Effects on Hypertension
por: Milling, Rikke Vilsbøll, et al.
Publicado: (2018)

Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA Trial
por: Kreissl, Michael C., et al.
Publicado: (2020)

Thyroid Nodules with Indeterminate FNAC According to the Italian Classification System: Prevalence, Rate of Operation, and Impact on Risk of Malignancy. An Updated Systematic Review and Meta-analysis
por: Trimboli, Pierpaolo, et al.
Publicado: (2022)

Update on Targeted Therapy in Medullary Thyroid Cancer
por: Okafor, Christian, et al.
Publicado: (2021)

Thirty synchronous medullary and papillary thyroid carcinomas
por: Zhang, Daqi, et al.
Publicado: (2023)

PET Imaging in Recurrent Medullary Thyroid Carcinoma
por: Treglia, Giorgio, et al.
Publicado: (2012)

(99m)Tc-Pertechnetate Scintigraphy Predicts Successful Postoperative Ablation in Differentiated Thyroid Carcinoma Patients Treated with Low Radioiodine Activities
por: Giovanella, Luca, et al.
Publicado: (2019)

Unilateral Surgery for Medullary Thyroid Carcinoma: Seeking for Clinical Practice Guidelines
por: Zhang, Daqi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_73p0h2p41urom72q9v8u38pf1o